Invesco Dynamic Pharmaceuticals ETF (PJP)

73.22
Delayed Data
As of May 19
 -0.21 / -0.29%
Today’s Change
70.83
Today|||52-Week Range
84.11
-9.75%
Year-to-Date

Investment Objective

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Pharma ETFs in Focus Post Q1 Earnings
May 12 / Zacks.com - Paid Partner Content
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
May 10 / Zacks.com - Paid Partner Content
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?
May 11 / Zacks.com - Paid Partner Content
 

Performance

1 month-7.99% 3 years+8.18%
3 months-0.81% 5 years+5.96%
1 year-5.03% Since inception+11.44%
Data through 05/18/2022

Quote Details

Previous close$73.43
Open day’s range72.83 – 73.22
Net asset value (NAV)73.37 (05/18/2022)
Daily volume3,035
Average volume (3 months)16,116
Data as of 3:43pm ET, 05/19/2022

Peer Comparisonvs. Health ETFs

 PJPCategory
Performance 5-yr return+5.96%+11.31%
Expense Gross exp ratio0.58%1.00%
Risk 5 year sharpe ratio0.340.52
Net assets$320.5M$1.9B
Average market cap$26.5B$41.8B
Average P/E19.325.8
Dividend / Share--0.26%

Competitors

IEHS iShares Evolved U.S. Healthcare Staples ...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.52%
Consumer goods 2.48%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
LLY Eli Lilly and Co6.47%
MRK Merck6.07%
JNJ Johnson & Johnson5.93%
AMGN Amgen5.60%
ABBV AbbVie5.59%
PFE Pfizer5.53%
GILD Gilead Sciences5.25%
ABT Abbott Laboratories5.23%
AMPH Amphastar Pharmaceuticals Inc4.10%
PCRX Pacira Biosciences Inc3.63%